title: Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation.
abstract: OBJECTIVE
  To analyze histopathologically and immunohistochemically the filtration bleb after unsuccessful glaucoma seton implantation.
  
  
  METHODS
  A von Denffer implant and two Molteno implants that were nonfunctional at three months, at 11 months, and at five years after implantation, respectively, were compared by evaluating the adjacent bleb with light microscopy and a panel of 11 antibodies to epithelial, mesenchymal, and inflammatory cells.
  
  
  RESULTS
  The wall of the filtration bleb three months after implantation consisted of loosely arranged collagenous connective tissue with relatively abundant fibroblasts labeled with monoclonal antibodies (MAbs) V9 and Vim 3B4 to vimentin. At 11 months and at five years, the collagenous layers had become increasingly thick and the fibroblasts scarce. All blebs showed metaplastic myofibroblasts surrounded by tenascin, as identified by MAb 1A4 to alpha-smooth muscle actin and TN2 to tenascin, respectively. One bleb was lined by a monolayer of cells that reacted with MAb CAM 5.2 and CY-90 to cytokeratin 8 and 18, respectively, and was apparently derived from the identically reacting proliferating corneal endothelial cells. Another bleb harbored many macrophages and foreign-body giant cells. Little evidence of chronic inflammation around the seton was detected.
  
  
  CONCLUSIONS
  A glaucoma seton may induce several processes that potentially decrease filtration. In addition to formation of a collagenous cyst, presence of myofibroblasts suggests long-standing scar modulation that potentially leads to compaction of the filtration membrane. Furthermore, macrophages and corneal endothelial cells may invade the filtration bleb.
authors.affiliation: Department of Ophthalmology, Helsinki University Central Hospital, Finland.
authors.forename: L
authors.initials: L
authors.lastname: Classen
authors.forename: T
authors.initials: T
authors.lastname: Kivelä
authors.forename: A
authors.initials: A
authors.lastname: Tarkkanen
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D003598:Cytoskeletal Proteins / Q000378:metabolism; D005109:Extracellular Matrix / Q000473:pathology; D005260:Female; D005347:Fibroblasts / Q000473:pathology; D018463:Filtering Surgery; D015743:Giant Cells, Foreign-Body / Q000473:pathology; D005901:Glaucoma / Q000601:surgery*; D006801:Humans; D007124:Immunoenzyme Techniques; D008264:Macrophages / Q000473:pathology; D008297:Male; D008875:Middle Aged; D018465:Molteno Implants / Q000009:adverse effects*; D010030:Ostomy; D011183:Postoperative Complications / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D012590:Sclera / Q000378:metabolism / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D003598:Cytoskeletal Proteins